Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights

Tune in to find out how lutetium-177and radium-223 can be used to treat patients with metastatic castration-resistant prostate cancer.

ReachMD Healthcare Image
Media formats available
  • Completing the pre-test is required to access this content.
    Pre-Survey
    Completing the pre-survey is required to access this content.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free